NootropicsDAO
DAO
Notropics
Live
Nootropics DAO is building the world's most effective global infrastructure for decentralized research, discovery, and commercialization of powerful solutions for human cognitive enhancement. By creating an open-science ecosystem that aligns professional researchers, citizen-scientists, and biohackers to govern a community-directed research and development pipeline with hyper-efficient feedback loops, Nootropics DAO is operating to become the dominant force in the rapidly growing nootropics industry.
Community Sentiment
MTK / USDTApr 11, 202608:44
$0.000009
+14.65%
Current Price$0.000009
ROI Since Raise0.000037x
24h Change+14.65%
24h Volume0.00 USD
Market Cap0.00 USD
Project Overview
Summary
SAggregate global demand for cognitive enhancers from pharmaceutical, plant-derived, and food-based sources
Problem
With the market for memory boosters, focus aids, brain health supplements, and general cognitive enhancers Estimated to reach more than $20 Billion over the next decade, the trend is clear. Nootropics, also known as "smart drugs", are here to stay.
Solution
Through its decentralized model, ValleyDAO empowers a global community to co-fund and collaborate on synthetic biology innovations, bridging science with a token-incentivized talent network to accelerate real-world impact. Its novelty lies in using IP Tokens and the GROW token to align incentives. IP Tokens let the community share in project success, while GROW enables voting on funding, rewards for co-development, and exclusive access to IP Token launches, aligning stakeholders toward shared goals.
Market Overview
+3.1°CPredicted global temperature increase by end of this century
80%Majority of synthetic biology funding flows to health, leaving climate application funding only at 20%
$3.4TSynthetic biology market potential by 2030 for non-medicine applications
Tokenomics
Token Distribution
Investors
20%Team
20%Airdrop
5%Community
5%Presale
50%Roadmap
Q1 2023
Launch of ValleyDAO token
Q1 2024
Announcement of Phlo
Q1 2026
Current
Planned tokenomics improvement & burn
Team
Albert Anis
Caltech Adv. Studies, Ex Novo Nordisk
Morgan Richards
DeepMind Scholar, Imperial College
Dan Hussey
IP Specialist, +10y Tech Transfer